Clinical trial
An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy, in the First-line Therapy of Recurrent/ Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
NCT01142869 is registered in ClinicalTrials.gov with Merck KGaA, Darmstadt, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy, in the First-line Therapy of Recurrent/ Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
- Lead sponsor
- Merck KGaA, Darmstadt, Germany
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 31, 2009
- Completion date
- August 5, 2014
- Enrollment
- 133 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.